Search
for
Sort by
Research 601–630 of 1000+
- Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
- Indications for a brain‐hair follicle axis: inhibition of keratinocyte proliferation and up‐regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P
- Obesity and polycystic ovary syndrome
- Autoimmune Polyglandular Syndrome Type 1 in Russian Patients: Clinical Variants and Autoimmune Regulator Mutations
- Effective medical treatment for common baldness in women
- Testosterone therapy in women: Myths and misconceptions
- Rabson-Mendenhall syndrome: two case reports and a brief review of the literature
- Dermatosis associated with menopause
- An overview of management of drug-induced hair and nail disorders
- Understanding polycystic ovary syndrome
- The combination of ethinylestradiol/cyproterone acetate is temporarily withdrawn from the market in France. Is the measure justified?
- Hair Disorders
- DHEA and TNF-α: Key Factors in Managing Polycystic Ovary Syndrome in Iraqi Females
- Hepatotoxicity Associated with Anabolic Androgenic Steroids and Selective Androgen Receptor Modulators: A Literature Review
- Unravelling the link between insulin resistance and androgen excess
- Modelling androgen synthesis and action during human sexual differentiation
- Dermatological manifestations associated with pregnancy
- Menopause - Andropause - Anti-Aging 2008, 11.-13. Dezember 2008, Wien - Abstracts
- Alopecia and hirsutism*
- Anti-androgen therapy in dermatology: a review
- Harmless Herbs? A Review of the Recent Literature
- Polycystic ovary syndrome: Challenges in adolescence
- Cutaneous Markers of Disorders Affecting Adult Horses
- Protective role of agomelatine via modulation of TLR4/NF-κB: NLRP3/IL-1β signaling pathways in testosterone-induced benign prostatic hyperplasia in rats
- Hair: A Review of Prominent Scalp Hair Changes throughout a Females’ Life
- 46, XY 5-Alpha Reductase Deficiency in a 36-Year-Old Phenotypic Female Patient
- Cutaneous calcinosis of scleroderma. Successful treatment with intralesional adrenal steroids.
- Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride.
- Mechanism of action of bolandiol (19-nortestosterone-3β,17β-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities
- Cell-free fat extract improves embryo development and clinical outcomes in older women with previous in-vitro fertilization failure